Evidence map›Paper›PMID 40140957›Full record

ArticleBiological research2025

Functional characterization of two KCND3 variants associated with SCA 19/22 ataxia in Latin American families.

Felipe Arancibia, Fernanda Martin, Jenny Ruiz-Fuentes, Erbio Diaz, Tamara Hermosilla, Wendy Gonzalez, Felipe Simon, Diana Avila-Jaque, Mariana Luna-Álvarez, David José Dávila Ortiz de Montellano and 3 more

Abstract read
In one paragraph

Article in Biological research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Felipe Arancibia *Programa de Fisiología y Biofísica, Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, 8380453, Santiago, Chile.
Fernanda Martin *Unidad Asesoramiento Genético Oncológico, Fundación Arturo López Pérez, Santiago, Chile.
Jenny Ruiz-FuentesPrograma de Fisiología y Biofísica, Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, 8380453, Santiago, Chile.
Erbio DiazMillennium Nucleus of Ion Channels-Associated Diseases (MiNICAD), Universidad de Chile, Santiago, Chile.
Tamara HermosillaPrograma de Fisiología y Biofísica, Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, 8380453, Santiago, Chile.
Wendy GonzalezMillennium Nucleus of Ion Channels-Associated Diseases (MiNICAD), Universidad de Chile, Santiago, Chile.
Felipe SimonMillennium Nucleus of Ion Channels-Associated Diseases (MiNICAD), Universidad de Chile, Santiago, Chile.
Diana Avila-JaqueHospital San Juan de Dios, Santiago, Chile.
Mariana Luna-ÁlvarezInstituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez, Mexico City, Mexico.
David José Dávila Ortiz de MontellanoInstituto Nacional de Neurología y Neurocirugía Manuel Velasco Suárez, Mexico City, Mexico.
Marcelo MirandaFundación Diagnosis, Santiago, Chile.
M Leonor BustamanteFundación Diagnosis, Santiago, Chile. mbustamante@uchile.cl.
Diego VarelaPrograma de Fisiología y Biofísica, Instituto de Ciencias Biomédicas, Facultad de Medicina, Universidad de Chile, 8380453, Santiago, Chile. dvarela@uchile.cl.ORCID http://orcid.org/0000-0002-9352-414X

Funding

Agencia Nacional de Investigación y Desarrollo BECAS DOCTORADO/2019 - 21190725Fondo Nacional de Desarrollo Científico y Tecnológico 1210881Ministerio de Economía, Fomento y Turismo, Chile MiNICAD
6 · The paper itself

Abstract

backgroundSpinocerebellar ataxia 19/22 (SCA19/22) represents a rare autosomal dominant genetic disorder resulting in progressive ataxia and cerebellar atrophy. SCA19/22 is caused by variants in the KCND3 gene, which encodes a voltage-gated potassium channel subunit essential for cerebellar Purkinje cell function. To date, 22 variants have been reported worldwide, with incomplete functional studies.

resultsWe present four Chilean and Mexican cases in whom two single-nucleotide variants were identified through whole-exome sequencing of the probands. One variant (G371R) was initially cataloged as pathogenic and the other (S357W) as likely pathogenic according to the American College of Medical Genetics and Genomics criteria. The pathogenicity of the G371R variation was confirmed by in-silico mutagenesis. Our molecular models, that include electrostatic potential analysis and algorithms to analyze the pore dimensions (HOLE), indicated that the longer side chain of the arginine narrowed the channel's selectivity filter, while the positive charge modified its surface electrostatic potential, presumably preventing potassium flux. Functional characterization of the S357W variant was performed in AD293 cells. When overexpressed, K

conclusionsThis functional characterization of two KCND3 variants associated with SCA19/22 adds new evidence for the pathogenic role of Kv4.3 loss-of-function mutations and establishes a correlation between functional dominance and clinical severity in SCA19/22.

Indexed as

Shal Potassium ChannelsSpinocerebellar AtaxiasSpinocerebellar DegenerationsAdultChileExome SequencingFemaleHumansMaleMexicoMiddle AgedPedigreeKCND3 protein, humanShal Potassium ChannelsCongenital ataxiaFunctional characterizationKCND3Kv4.3Spinocerebellar ataxia SCA19/22

Identifiers

PMID40140957
PMCPMC11938557

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.